ORAGENICS, INC. Prepaid Expense, Noncurrent
ORAGENICS, INC. (OGEN) had Prepaid Expense, Noncurrent of $1.09 million as of 2023-12-31, per its 10-K filed 2025-03-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PrepaidExpenseNoncurrent · last filed 2025-03-14
- 2023-12-31: Prepaid Expense, Noncurrent $1.09M.
| Period end | Prepaid Expense, Noncurrent |
|---|---|
| 2023-12-31 | $1.09M 10-K · filed 2025-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |